NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Name: NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Published: 2025
License: Public Domain

Neurocrine Biosciences · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

depression major-depressive-disorder

major depressive disorder, mdd, depression, nbi-1065845, tak-653, madrs, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Related documents